{"id":21681,"date":"2022-12-19T10:00:06","date_gmt":"2022-12-19T09:00:06","guid":{"rendered":"https:\/\/idibell.cat\/en\/?p=21681"},"modified":"2022-12-16T15:59:05","modified_gmt":"2022-12-16T14:59:05","slug":"hna-foundation-collaborates-in-the-development-of-a-new-drug-against-inflammatory-bowel-diseases","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2022\/12\/hna-foundation-collaborates-in-the-development-of-a-new-drug-against-inflammatory-bowel-diseases\/","title":{"rendered":"hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases"},"content":{"rendered":"

hna Foundation collaborates with IDIBELL’s research on inflammatory bowel diseases, specifically the group on “Immuno-inflammatory Processes and Gene Therapy”, led by Dr. Josep Maria Aran. This donation will promote the development of a new drug for inflammatory bowel diseases (IBD) treatment, as highlighted by the researcher, who has transmitted his great gratitude to the Foundation.<\/p>\n

In Spain, the incidence of IBD is 16 cases per 100,000 people\/year, which means approximately 10,000 new cases each year. Autoinflammatory diseases correspond to an abnormal regulation of the immune system that causes persistent inflammation in the gastrointestinal tract. IBDs place a significant burden on the health system. On the other hand, current treatments are ineffective and have very significant side effects.<\/p>\n

Dr. Aran’s group has discovered a protein that induces a transition from a pro-inflammatory to an anti-inflammatory state of immune cells, which could slow down the progression of these diseases. The compound corresponds to a restructuration of a regulatory protein of the innate immune system, our body’s first line of defense.<\/p>\n

With this project funded by hna Foundation, the researchers intend to develop and characterize this new biological immunomodulator through cutting-edge technologies<\/p>\n","protected":false},"excerpt":{"rendered":"

This support will help to develop and characterize a new immunomodulatory compound discovered by the IDIBELL group led by Dr. Josep Maria Aran.<\/p>\n","protected":false},"author":8,"featured_media":21682,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[262,197,300],"tags":[],"class_list":["post-21681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genes-disease-and-therapy-program","category-immune-inflammatory-processes-and-gene-therapeutics","category-translational-medicine-area"],"publishpress_future_action":{"enabled":false,"date":"2025-01-22 02:09:45","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/21681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=21681"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/21681\/revisions"}],"predecessor-version":[{"id":21683,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/21681\/revisions\/21683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/21682"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=21681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=21681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=21681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}